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Summary The distribution of iron and iron binding proteins (IBP) have been compared with control spleen
tissue in an attempt to establish a pattern of staining restricted to Hodgkin's disease (HD). All but one of the
HD spleens examined stained for ferritin, which was largely present in red pulp dendritic macrophages (DM).
In spleens histologically involved with HD heavy deposits of ferritin were seen around tumour nodules.
Staining for ferritin increased with involvement of the spleen in HD but DM still represented the bulk of
positive cells. However, ferritin positive DM were frequently seen in control spleens, and often in large
numbers. Staining of ferric iron by Perls technique was less prominent than ferritin but this observation was
also true of the non-HD spleens studied. Patterns of staining with transferrin were equivalent in both groups
of spleens with DM being the most frequently positive cell type.
Polymorphous macrophages showing erythrophagocytosis were present in the red pulp sinuses of all groups
of spleens and although these cells have been considered as precursors of the Reed-Sternberg cell their
presence seemed related to total splenic ferritin regardless of the diesase process. These cells marked as
macrophages and their presence was not restricted to HD.
The results show that there is no particular appearance of iron or IBP distribution which is restricted to
HD spleens. However, staining for ferritin and iron increased in HD spleens with tumour involvement and
could contribute to circulatory abnormalities in this disease.
Hodgkin's disease (HD) is a progressive disorder of'
the lymphoid system often accompanied by a
deficiency in cell mediated immunity (Hansen &
Good, 1974; Kaplan, 1976). The depression of cell
mediated immunity in HD has been related to
increased activity of suppressor cells (Twomey et
al., 1980; Hillinger & Herzig, 1978; Goodwin et al.,
1977; Sibbett et al., 1978), the presence of circu-
lating inhibitory factors (Siegal, 1976; Fuks et al.,
1976; Moroz et al., 1977), and, in advanced
disease, decreased numbers of T-cells, (Aiuti et al.,
1973; Bukowski et al., 1976). De Sousa et al. (1977)
have reported poor proliferative responses to phyto-
haemaglutinin (PHA) of peripheral blood lympho-
cytes from patients with HD when compared
with normal controls, corrected by splenectomy.
This data coupled with observations of increased
T-cell percentages in the spleens from patients with
HD (Kaur et al., 1974; Payne et al., 1976; Gupta,
1980) led De Sousa et al. (1977) to postulate that
depressed cell immunity in the blood is a conse-
quence of the sequestration of a particular T-cell
subset in the spleen and further to suggest that
this may be associated with the presence of iron
binding proteins (IBP) in the cells of the
reticuloendothelial system (De Sousa et al., 1978).
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Anomalies of iron handling by the phagocytic
system in HD were first described by Beamish et al.
(1972). De Sousa et al. (1977) examined iron
deposition and the distribution of IBP in five
spleens involved with the disease and one non-
Hodgkin's lymphoma control. IBP were identified
by immunofluorescent staining of frozen sections
and iron by Perls Prussian blue technique. These
results claimed a relationship between the dis-
tribution in the spleen of iron and IBP and
involvement with HD. Smithyman et al. (1979)
confirmed that elevated levels of ferritin were found
in frozen sections of HD spleens, but again the
study was small and the frozen section technique
employed gave poor morphological detail. These
reports suggest a specific relationship between IBP
and, or, iron and the development of a cellular
defect in HD. We were doubtful that this was so
and this scepticism prompted us to study the
distribution of iron and IBP not only in HD but
also in other disorders including non-Hodgkin's
lymphomas, thalassaemia and carcinoma where the
haematological changes associated with HD may
not occur.
We present the results of a study of splenic tissue
from 63 cases of lymphoma, 49 of which were from
patients with HD. Various non-lymphomatous
control spleens were included in the study incorpo-
rating spleens from patients with thalassaemia, a
disease with a known abnormality in iron
metabolism.
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The study is intended to demonstrate conclusively
whether a particular distribution or quantity of one
or more of the IBP or haemosiderin within the
spleen is restricted to HD.
Materials and methods
In total 95 spleens were studied; 49 were from
patients with HD of which 28 cases showed splenic
involvement; 14 spleens were obtained at operation
from patients with non-Hodgkin's lymphoma. The
remaining 32 cases were from non-lymphomatous
conditions, 6 were from thalassaemic patients; 6
from normal healthy individuals removed post
trauma and 26 were removed from patients
incidental to abdominal surgery. We acknowledge
the co-operation of the surgeons at Southampton
General Hospital and Memorial Sloan-Kettering
Cancer Centre, New York.
Sections were cut from neutral buffered formalin
fixed paraffin embedded material, deparaffinised in
xylol, rehydrated through graded alcohols to water
and treated with 0.5% hydrogen peroxide in
methanol to block endogenous peroxidase activity.
Sections to be stained for IBP were then treated
according to the peroxidase-anti-peroxidase (PAP)
method with prior trypsinisation (Mepham et al.,
1979). Briefly, this procedure involves incubating
the sections in 0.1% trypsin (Sigma Chemical
Company, Poole) in 0.1% calcium chloride, pH7.8,
at 37°C for 10-15min followed by washing first in
water and then in Tris buffered saline (TBS; 0.5 M
Tris HCl, pH7.6 diluted 1:10 with 0.15M saline).
The sections were stained with the appropriate
rabbit antiserum followed by swine anti-rabbit IgG
and then rabbit PAP complexes (Dakopatts AS,
Copenhagen). Each incubation lasted 30min, and
was followed by three 10min washes in TBS.
Bound peroxidase labelled antibody was revealed
by the application of 3,3' diaminobenzidene to give
a brown reaction product. Sections were counter-
stained with haematoxylin. Sections in which the
specific antiserum stage was omitted were also
prepared as controls. The specificity of the antisera
was established prior to staining by radial immuno-
diffusion and immunoelectrophoresis against the
appropriate antigen. The specificities of the anti-
ferritin, anti-transferrin and anti-lactoferrin were
confirmed by absorption with purified antigen.
All spleen sections were also stained for





Spleens from patients with Hodgkin's disease were
divided into 2 groups, those with histological
evidence of disease involvement and those without.
Involved spleens All of the involved spleens were
positive for ferritin which was found predominantly
in red pulp dendritic macrophages (DM) (Figure 1).
Generally staining was strong, exceptionally only a
few weakly poisitive DM were seen. Positive DM
were often found in large numbers at the periphery
of tumour nodules which were themselves negative
(Figure 1). In spleens showing strong ferritin
staining positive cells were also present free in the
red pulp sinuses. These often appeared to be
vacuolated or possibly to be binucleate and were
termed sinus cells (SC) (Figure 2). The number of
SC seen varied considerably between spleens.
Ferritin positive macrophages with foamy
cytoplasm were noted in a small number of the
strongly staining sections.
Uninvolved spleens The intensity and number of
ferritin positive cells varied considerably in the 21
uninvolved spleens, but all except one case had
positive staining of DM in the red pulp. SC were
seen in seven spleen sections with one case
containing numerous strongly stained SC. Three
cases also contained weakly staining foamy
macrophages.
Table I Staining of cell populations in spleen for ferritin (% positive cases)
Hodgkin's disease Non-Hodgkin's
Involved Uninvolved Thalassaemia lymphomaa Controlsb
Red pulp DM 100 95 100 86 73
Sinus cells 82 33 83 21 35
Number of cases 28 21 6 14 26
aNon-Hodgkin's lymphoma includes lymphomas of a true FCC origin plus other types; bControl
group includes all control and normal spleens.SPLENIC IRON IN HODGKIN'S DISEASE 279
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Figure 1 A. Shows the distribution of ferritin positive DM in the red pulp and also at the periphery of a
tumour nodule (T) in a spleen involved with HD. ( x 80). B. High power view of ferritin positive cells adjacent
to tumour nodule of HD tissue. ( x 800). C. High power view of ferritin positive cells in the red pulp. ( x 800).
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Figure 2 High power view of SC stained for ferritin (F) and ferric iron (I) within red pulp sinuses of HD
spleens. (x 1600).
Control spleens
Control spleens displayed great variation in
ferritin staining but again DM were the pre-
dominantly stained population. SC were seen in
spleen sections from three strongly ferritin positive
cases (Figure 3).
Normal spleens
Six normal spleens obtained following traumatic
injury showed in three cases moderate staining of
DM for ferritin with a few ferritin positive SC in
the red pulp of two of these cases.
Thalassaemic spleens
Spleens from the six thalassaemia patients studied
contained ferritin positive DM in the red pulp. In
two cases (Southampton) a few SC were seen to be
stained with ferritin. The four remaining cases
Figure 3 Ferritin positive DM and SC in a spleen removed from a patient with carcinoma of the stomach.
( x80).
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(New York) were all strongly positive for ferritin
and three of these cases had ferritin positive SC
(Figure 4).
Non-Hodgkin's lymphoma spleens
This section includes the Follicle Centre Cell (FCC)
lymphomas and other types of non-Hodgkin's
lymphoma. The FCC lymphoma spleens all had
strongly ferritin positive DM within the red pulp.
Ferritin positive SC were seen in three of the
sections which also had positively stained macro-
phages within the white pulp (Figure 5). In two of
these three cases ferritin appeared free within the
sinuses.
The remaining non-Hodgkin's lymphomas had
DM positive for ferritin. Ferritin staining was seen
in the sinuses of two cases and three sections
showed positive foamy macrophages.
IRON (Table II)
Hodgkin's disease
Involved spleens All 28 cases had some positive
staining for ferric iron with a distribution similar to
that shown for ferritin. The intensity of staining
was weaker. In the spleens with numerous cells
positive for iron granular and diffuse cytoplasmic
staining patterns occurred (Figure 6). In some cases
DM with strongly stained granular deposits were
seen around areas of tumour with a similar pattern
to that seen in the ferritin stained sections. SC were
stained less frequently by Perls technique when
compared to cases stained for ferritin (Figure 2).
Two cases had iron positive foamy macrophages.
Uninvolved spleens Uninvolved spleens were
generally negative for ferric iron or had only
weakly iron positive DM. Three cases which
showed strong ferritin staining and many ferritin
positive SC were also strongly positive for iron
which was either granular or diffuse in DM. Perls
positive material was seen in many sinuses in these
spleens, with iron positive SC in two sections. A
few Perls positive SC were also present in two of
the spleens.
Control spleens
Staining for ferric iron varied from negative to
strongly positive with DM the predominant positive
cell type. One case had iron positive SC.
Normal spleens
The six normal spleens had only scanty Perls
positive DM, with a few sinuses positive for iron in
four cases. Rare iron stained SC were present in
two spleen sections.
Figure 4 Ferritin positive DM and SC in a spleen removed from a patient with thalassaemia. ( x 80).282 K.J.M. BRITTEN et al.
Figure 5 Ferritin positive DM and SC in a spleen removed from a patient with FCC lymphoma. ( x 80).
Note the positive DM in areas of tumour involvement (T).
Figure 6 A. Shows the distribution of ferric iron positive DM in the red pulp and also at the periphery of a
tumour nodule in a spleen involved with HD. ( x 80). B. High power view of granular staining DM. ( x 800).
C. High power view of diffuse staining DM. (x 800).SPLENIC IRON IN HODGKIN'S DISEASE 283
Table II Staining of cell populations in spleen for ferric iron (% positive cases)
Hodgkin's disease Non-Hodgkin's
Involved Uninvolved Thalassaemia lymphomaa Controlsb
Red pulp DM 100 86 100 64 62
Sinus cells 47 21 83 14 23
Number of cases 28 21 6 14 26
aNon-Hodgkin's lymphoma includes lymphomas of a true FCC origin plus other types; bControl
group includes all control and normal spleens.
Thalassaemic spleens
Staining for iron was very strong in the
thalassaemic spleen sections. Numerous DM and
several endothelial cells lining the sinuses were
strongly Perls positive. Iron containing SC were
seen in five of the cases.
Non-Hodgkin's lymphoma spleens
Ferric iron in the sections of the FCC lymphoma
showed a similar distribution to that described for
ferritin but was weaker. All cases had granular iron
deposits in DM. Sinuses containing iron were seen
in the same 2 cases which were positive for ferritin.
Iron poisitive SC were also present in these spleens.
Four of the nine other non-Hodgkin's lymphoma
spleens had iron positive DM in the red pulp. SC in
these spleens were not stained for iron.
TRANSFERRIN (Table III)
Some of the spleen sections in all the groups
studied had weak staining of the serum and of the
connective tissue for transferrin.
Hodgkin's disease
HD spleens frequently showed some positive
staining for transferrin, usually in DM. Positive
cells were less frequent in uninvolved than involved
spleens. Several cases had strongly transferrin
positive DM often around the tumour nodules in
the HD involved spleen sections. DM were less
frequently stained in the white pulp. A quarter of
the HD involved cases had transferrin positive
Reed-Sternberg or mononuclear Hodgkin's cells
and some also had SC staining for transferrin
(Figure 7). Some HD involved spleen sections had
transferrin positive lymphocytes.
Control spleens
Strongly transferrin positive DM were seen in the
red pulp of three cases and in one of these a few
follicles contained some strongly transferrin positive
DM otherwise the sections were weakly positive or
negative.
Normal spleens
Of the six cases of normal spleen two had
numerous transferrin positive DM in the red pulp.
The other sections had minimal staining.
Thalassaemic spleens
Two of the six cases studied exhibited a few
transferrin posotive DM in the red pulp.
Non-Hodgkin's lymphoma spleens
Spleen sections from the cases of FCC lymphomas
all had a similar staining pattern but with varying
degrees of intensity. The only type of cell that was
stained for transferrin were the DM in the red pulp,
except for one case which had a few weak positive
white pulp DM. In three of the remaining non-
Hodgkin's lymphomas foamy macrophages stained.
Table III Staining of cell populations in spleen for transferrin (% positive cases)
Hodgkin's disease Non-Hodgkin's
Involved Uninvolved Thalassaemia lymphomaa Controlsb
Red pulp DM 100 67 33 79 46
White pulp DM 43 43 0 36 8
Sinus cells 21 5 0 0 0
Number of cases 28 21 6 14 26
aNon-Hodgkin's lymphoma includes lymphomas of a true FCC origin plus other types; bControl
group includes all control and normal spleens.284 K.J.M. BRITTEN et al.
Figure 7 Shows the distribution of transferrin positive cells in the red pulp and tumour nodule (T) of
involved HD spleen. ( x 80).
Neoplastic cells showed bound transferrin in five of
the nine cases.
LACTOFERRIN
The staining patterns obtained with lactoferrin
appeared to have no obvious relationship to the
condition of the spleen. Two types of lactoferrin
positive cells were seen. The most frequently
observed were polymorphonuclear leucocytes which
stained variably. DM within the red pulp were also
lactoferrin positive and often stained along the
length of the dendritic processes. Occasionally
lactoferrin positive material was seen close to the
nucleus, possibly in association with the Golgi
apparatus.
Discussion
Immunological studies on HD have demonstrated
that a defect in cell mediated immunity is present in
the early stages of disease (Schier et al., 1956),
although absolute T- and B-cell numbers in
peripheral blood remain within the normal range,
except in advanced stages of disease (Kaur et al.,
1974; Young et al., 1972; Case et al., 1976). The
depression of cell mediated immunity may reflect a
reduction of a specific T-cell subset in the
peripheral blood due to sequestration in another
site such as the spleen. Payne et al. (1976)
demonstrated elevated mean T-cell values in spleens
from adult HD patients, but no simultaneous
peripheral blood values were taken. Further work
by De Sousa et al. (1977) employed the peripheral
blood response to the mitogen PHA as an indicator
of T-cell function before and after splenectomy in
children with HD stage IA. The results showed a
PHA response return to within the normal range 18
months after splenectomy compared to a signi-
ficantly lower value in a non-splenectomised HD
patient. Further, Gupta (1980) demonstrated an
increased proportion of T suppressor cells in
peripheral blood and increased proportions of T
inducer cells relative to T suppressor cells in the
spleen of HD patients, results which appear to
confirm the sequestration of a T-cell subset.
The cause of the selective migration into the
spleen in HD of a specific T-cell subset is not clear.
Iron and the iron binding proteins (IBP) may be
involved as they have been shown to be altered in
HD patients compared to normal controls. Jaffe et
al. (1970) demonstrated a decrease in the level of
serum iron in HD patients with clinically advanced
HD. Jones et al. (1972) have shown that patients
with HD and leukaemia have about ten times the
average amount of serum ferritin, associated with a
decrease in both serum iron and transferrinSPLENIC IRON IN HODGKIN'S DISEASE 285
saturation, a change indicative of a shift of iron
from the plasma transferrin pool to the reticulo-
endothelial ferritin pool and supported by increased
ferritin staining in macrophages in spleens from
HD patients. Increased levels of ferritin were also
detected in the serum and splenic cells of HD
patients by Bieber and Bieber (1973) and in
peripheral blood lymphocytes and spleen cell
homogenates by Eshaar et al. (1974). More recently
iron and IBP were considered to be elevated in
spleens from HD patients (De Sousa et al., 1978;
Smithyman et al., 1979). The most striking feature
of the latter study was the distribution of ferritin
within the spleens. The majority of the ferritin
positive cells were DM in the red pulp. De Sousa et
al. (1978) demonstrated large numbers of ferritin
containing cells in areas of spleen involved with
HD but also found that these cells, although not so
numerous, stained in the uninvolved spleens.
However, as morphological detail is often poor
with immunofluorescence on frozen sections the
ferritin positive cell types could not be identified.
Further, Smithyman et al. (1979) again demon-
strated ferritin positive material in all sections of
spleen from patients with HD. Heavy deposits of
ferritin were also observed at the periphery of
tumour nodules in the involved spleens. Our results
are in agreement with these authors in that ferritin
positive DM, often very strongly stained, were seen
around areas of tumour which were themselves
negative. The degree of ferritin staining increased
with involvement of the spleen in HD but the main
cell type, red pulp DM, did not vary. Red pulp
DM were also the major ferritin containing cell
type in all the control spleens. Some of the control
spleen sections contained considerable numbers of
ferritin containing cells, notably those from patients
with thalassaemia and FCC lymphoma.
Large polymorphous cells were seen in the heavily
stained ferritin spleens. They appeared to be
vacuolated. They were most often seen in red pulp
sinuses, hence the name sinus cells (SC). De Sousa
et al. (1978) observed this type of cell in spleen
smears, but could not distinguish them in spleen
sections using immunofluorescence. Smithyman et
al. (1979) again using an immunofluorescent
technique also described what appears to be the
same type of cell, but commented they were found
in the band of sclerotic tissue surrounding the
tumour nodules in involved HD spleens. In a few
cases SC were seen in greater numbers around
tumour nodules. Smithyman et al. (1979) proposed
that these cells may possibly be the Reed-Sternberg
or mononuclear HD cells but they were always
found to be negative for ferritin in the spleens
in this study. It is claimed that cells containing
IBP could be precursors of the neoplastic cells in
HD. In fact Reed-Stemnberg and mononuclear
Hodgkin's cells were observed to stain for
transferrin whilst SC generally did not do so.
Further, if SC are a specific feature of HD they
should not be seen in spleens other than those
obtained from HD patients. However in the control
spleen sections with moderate or heavy staining for
ferritin SC were seen, and also in the thalassaemic
spleens where extensively deposited iron is regularly
observed. SC are therefore not a unique feature of
HD but are found in any spleen in a state of iron
overload.
Spleen sections stained by Perls Prussian blue
technique for ferric iron showed the same staining
pattern as for ferritin but the staining was generally
weaker. The difference that is seen between the
iron and ferritin positive cells cannot be readily
explained as ferric iron stained by Perls technique
should include that iron within the ferritin molecule
(Richter, 1978). It is possible that the immuno-
peroxidase technique is more sensitive than Perls
Prussian blue method. Another possible explanation
is that the ferritin present is in the form of
apoferritin, that is, it contains no iron. It is possible
that the apoferritin is produced by a stimulus other
than an increase in serum iron concentration (which
has been shown by Jaffe et al. (1970) to be
decreased in HD) and as a consequence serum iron
is taken up by ferritin producing DM and not
released. This would explain the decreased demon-
stration ofiron compared with ferritin in the spleens
from patients with malignant disease and would
imply that the primary cause of the anaemia
associated with advanced disease is a result of
increased ferritin production due to changes caused
by the disease process.
The difference in the two staining patterns shown
in the spleens stained by Perls technique of a
granular or diffuse distribution of the iron in the
normal situation is due to the stage at which the
macrophage had reached in the process occurring
after iron uptake. The diffuse cytoplasmic staining
is due to iron binding to apoferritin that is formed
on ingestion of iron, whereas the blue granular
stain shows a concentration of iron in secondary
lysosomes or in multivesicular bodies (Richter,
1978).
It is not possible to say from the observations
made here if the increased ferritin and iron in the
spleens from HD patients is a result or a cause of
the disease but it can be stated that an increase in
staining for ferritin and iron occurred with
increased involvement of the spleen with HD.
Part of this work was included in a thesis for Fellowship
submitted to the Institute of Medical Laboratory Sciences
by K.J.M. Britten.286 K.J.M. BRITTEN et al.
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